
- Summer 2010
- Volume 2
- Issue 2
Truly Community-Based Oncology
As 2010 has rolled along, the Intellisphere Oncology Specialty Group has aimed to uphold its mission of Bringing the Oncology Community Together.
As 2010 has rolled along, the Intellisphere Oncology Specialty Group has aimed to uphold its mission of Bringing the Oncology Community Together. In March, we covered The Third Annual Interdisciplinary Prostate Cancer Congress (IPCC) in New York, New York. The session’s theme was “Translating Advances into Clinical Practice,” and it featured renowned prostate cancer experts. ArcMesa Educators organized the well-attended event, which was open to urologists, radiologists, and medical oncologists. The IPCC was so well received that planning has started for next year’s Congress. Look for IPCC coverage in this issue; and for additional information, read our IPCC feature in the April 2010 issue of our sister publication Oncology & Biotech News.
With the arrival of summer, we announced our new partnership with the National Coalition of Oncology Nurse Navigators (NCONN;
Speaking of OncLive, in June we launched the 2.0 version of the flagship Website for Contemporary Oncology, Oncology & Biotech News, Oncology Net Guide, and OncLive Nursing. The easily navigable, redesigned site includes issue archives, conference coverage, blogs, informational videos, patient resource guides, and Web exclusives. We also created a social media platform that aggregates Twitter feeds from leading oncology organizations and physicians. Our goal is to maintain a Web presence that facilitates interaction and information exchange among the oncology community. To submit feedback and suggestions for the new OncLive, e-mail us at
As we head toward 2011 and beyond, we will also continue to update you on the best available oncology resources. For example, now through November of next year, our sister publication Pharmacy Times is offering the CE, No Bones About It: The Pharmacist’s Role in Managing Cancer Therapy—Induced Bone Loss (
Articles in this issue
almost 15 years ago
The Proactive Patient: 10 Questions for Your Cancer Care Teamalmost 15 years ago
Clinician's View: Making Survival a Blessing, Not a Burdenalmost 15 years ago
The Downside to Beating the Oddsalmost 15 years ago
Biomarkers in Ovarian Cancer: Early Detection and Chemoresistancealmost 15 years ago
Managing the Side Effects of Androgen-Deprivation Therapyalmost 15 years ago
Summer FDA Updatesalmost 15 years ago
Tasigna Moves to the Front-Line in CMLalmost 15 years ago
Jevtana Approved for Advanced Prostate Cancer


































